Eledon Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Eledon Pharmaceuticals, Inc. (ELDN) had Shares Outstanding (Cover Page) of 81.26 million shares as of 2026-08-10, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-10: Entity Common Stock, Shares Outstanding 81.26M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 77.19M shares.
- 2026-03-13: Entity Common Stock, Shares Outstanding 75.85M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 59.93M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 81.26M shares 10-Q · filed 2026-08-13 |
| 2026-05-07 | 77.19M shares 10-Q · filed 2026-05-13 |
| 2026-03-13 | 75.85M shares 10-K · filed 2026-03-19 |
| 2025-11-07 | 59.93M shares 10-Q · filed 2025-11-14 |
| 2025-08-13 | 59.88M shares 10-K/A · filed 2025-08-14 |
| 2025-08-12 | 59.88M shares 10-Q/A · filed 2025-08-14 |
| 2025-05-08 | 59.88M shares 10-Q · filed 2025-05-14 |
| 2025-03-17 | 59.88M shares 10-K · filed 2025-03-20 |
| 2024-11-08 | 59.74M shares 10-Q · filed 2024-11-12 |
| 2024-08-14 | 39.66M shares 10-K/A · filed 2024-08-19 |
| 2024-05-10 | 38.51M shares 10-Q/A · filed 2024-08-19 |
| 2024-03-25 | 24.81M shares 10-K/A · filed 2024-04-26 |
| 2023-11-07 | 24.20M shares 10-Q · filed 2023-11-09 |
| 2023-08-08 | 23.55M shares 10-Q · filed 2023-08-10 |
| 2023-05-10 | 22.51M shares 10-Q · filed 2023-05-11 |
| 2023-03-29 | 13.78M shares 10-K · filed 2023-03-30 |
| 2022-11-10 | 13.76M shares 10-Q · filed 2022-11-14 |
| 2022-08-10 | 13.76M shares 10-Q · filed 2022-08-11 |
| 2022-05-11 | 13.76M shares 10-Q · filed 2022-05-12 |
| 2022-03-22 | 14.31M shares 10-K · filed 2022-03-24 |
| 2021-11-08 | 14.31M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 14.31M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 14.31M shares 10-Q · filed 2021-05-14 |
| 2021-03-23 | 14.31M shares 10-K · filed 2021-03-31 |
| 2020-11-13 | 1.43M shares 10-Q · filed 2020-11-16 |
| 2020-08-11 | 19.38M shares 10-Q · filed 2020-08-14 |
| 2020-05-11 | 16.07M shares 10-Q · filed 2020-05-15 |
| 2020-03-09 | 16.07M shares 10-K · filed 2020-03-17 |
| 2019-11-11 | 12.97M shares 10-Q · filed 2019-11-13 |
| 2019-08-12 | 12.97M shares 10-Q · filed 2019-08-13 |
| 2019-05-10 | 12.90M shares 10-Q · filed 2019-05-14 |
| 2019-03-22 | 9.43M shares 10-K · filed 2019-03-28 |
| 2018-11-08 | 9.42M shares 10-Q · filed 2018-11-13 |
| 2018-08-03 | 9.42M shares 10-Q · filed 2018-08-07 |
| 2018-05-07 | 9.41M shares 10-Q · filed 2018-05-11 |
| 2018-03-23 | 9.41M shares 10-K · filed 2018-04-02 |
| 2017-11-06 | 7.09M shares 10-Q · filed 2017-11-08 |
| 2017-08-04 | 6.94M shares 10-Q · filed 2017-08-09 |
| 2017-04-30 | 22.64M shares 10-Q · filed 2017-05-03 |
| 2017-01-31 | 22.64M shares 10-K · filed 2017-03-03 |
| 2016-10-31 | 22.64M shares 10-Q · filed 2016-11-03 |
| 2016-07-31 | 22.63M shares 10-Q · filed 2016-08-04 |
| 2016-04-30 | 22.63M shares 10-Q · filed 2016-05-10 |
| 2016-02-29 | 22.63M shares 10-K · filed 2016-03-10 |
| 2015-10-31 | 22.58M shares 10-Q · filed 2015-11-10 |
| 2015-07-31 | 22.55M shares 10-Q · filed 2015-08-12 |
| 2015-04-30 | 22.41M shares 10-Q · filed 2015-05-12 |
| 2015-03-15 | 22.38M shares 10-K · filed 2015-03-26 |
| 2014-11-10 | 22.38M shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |